Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-24 @ 10:09 PM
NCT ID:
NCT05530135
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with takotsubo cardiomyopathy in the previous three weeks
* Participant who is willing and able to give informed consent for participation in the study.
* Participant who is willing to travel to Aberdeen Royal Infirmary for the study visits.
* Healthy volunteers (for blood and saliva samples only) willing to give informed consent for participation in the study. Healthy volunteers should not be on any medication.
* For influenza T-Cell testing: healthy volunteers who have recently received their annual flu vaccination.
* Myocardial Infarction (MI) comparators: patients with type 1 acute MI (diagnosed within the last three weeks)
Exclusion Criteria:
* Any patient whose takotsubo cardiomyopathy was triggered by a physical illness that would preclude them from taking part in a physical exercise training program
* Any patient who is not able or willing to travel to the cardiovascular research facility for their study visits
* Any patient who is not able to commit to a 12 week supervised training program
* Inability to exercise on a cycle ergometer or a treadmill (e.g. use of walking aids or prosthetic limbs or advanced frailty)
* Unwillingness to participate
* Contraindication to MRI scanning such as implantable cardiac devices.
* Pregnancy
* Healthy volunteers taking medication
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05530135
Study Brief:
Protocol Section:
NCT05530135